BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8567656)

  • 1. The amino-terminal one-third of alpha IIb defines the ligand recognition specificity of integrin alpha IIb beta 3.
    Loftus JC; Halloran CE; Ginsberg MH; Feigen LP; Zablocki JA; Smith JW
    J Biol Chem; 1996 Jan; 271(4):2033-9. PubMed ID: 8567656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of ligand recognition by integrin alpha 5beta 1. I. Specificity of ligand binding is determined by amino acid sequences in the second and third NH2-terminal repeats of the alpha subunit.
    Mould AP; Askari JA; Humphries MJ
    J Biol Chem; 2000 Jul; 275(27):20324-36. PubMed ID: 10764748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGD-containing peptides inhibit fibrinogen binding to platelet alpha(IIb)beta3 by inducing an allosteric change in the amino-terminal portion of alpha(IIb).
    Basani RB; D'Andrea G; Mitra N; Vilaire G; Richberg M; Kowalska MA; Bennett JS; Poncz M
    J Biol Chem; 2001 Apr; 276(17):13975-81. PubMed ID: 11278919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of a ligand binding domain of beta 3 integrin. Integral role of oxygenated residues in alpha IIb beta 3 (GPIIb-IIIa) receptor function.
    Bajt ML; Loftus JC
    J Biol Chem; 1994 Aug; 269(33):20913-9. PubMed ID: 7520434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential recognition of snake venom proteins expressing specific Arg-Gly-Asp (RGD) sequence motifs by wild-type and variant integrin alphaIIbbeta3: further evidence for distinct sites of RGD ligand recognition exhibiting negative allostery.
    Rahman S; Flynn G; Aitken A; Patel Y; Hussain F; Lu X; Loftus JC; French D; Wijelath E; Strand K; Savidge GF
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):701-9. PubMed ID: 10642531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple discontinuous ligand-mimetic antibody binding sites define a ligand binding pocket in integrin alpha(IIb)beta(3).
    Puzon-McLaughlin W; Kamata T; Takada Y
    J Biol Chem; 2000 Mar; 275(11):7795-802. PubMed ID: 10713093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in the integrin alphaIIb subunit that selectively inhibits alphaIIb beta3 receptor function.
    Perkins KB; Loftus JC
    Thromb Haemost; 2003 Nov; 90(5):853-62. PubMed ID: 14597981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3).
    Biris N; Abatzis M; Mitsios JV; Sakarellos-Daitsiotis M; Sakarellos C; Tsoukatos D; Tselepis AD; Michalis L; Sideris D; Konidou G; Soteriadou K; Tsikaris V
    Eur J Biochem; 2003 Sep; 270(18):3760-7. PubMed ID: 12950259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The exchange of Arg-Gly-Asp (RGD) and Arg-Tyr-Asp (RYD) binding sequences in a recombinant murine Fab fragment specific for the integrin alpha IIb beta 3 does not alter integrin recognition.
    Kunicki TJ; Ely KR; Kunicki TC; Tomiyama Y; Annis DS
    J Biol Chem; 1995 Jul; 270(28):16660-5. PubMed ID: 7542651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine 752 in the cytoplasmic domain of the beta 3 integrin subunit is not required for alpha v beta 3 postreceptor signaling events.
    Kieffer N; Melchior C; Guinet JM; Michels S; Gouon V; Bron N
    Cell Adhes Commun; 1996 Jul; 4(1):25-39. PubMed ID: 8870971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for distinctive recognition of fibrinogen gammaC peptide by the platelet integrin alphaIIbbeta3.
    Springer TA; Zhu J; Xiao T
    J Cell Biol; 2008 Aug; 182(4):791-800. PubMed ID: 18710925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation in the alpha subunit of the platelet integrin alphaIIbbeta3 identifies a novel region important for ligand binding.
    Tozer EC; Baker EK; Ginsberg MH; Loftus JC
    Blood; 1999 Feb; 93(3):918-24. PubMed ID: 9920841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand binding to integrin alpha(v)beta(3) requires tyrosine 178 in the alpha(v) subunit.
    Honda S; Tomiyama Y; Pampori N; Kashiwagi H; Kiyoi T; Kosugi S; Tadokoro S; Kurata Y; Shattil SJ; Matsuzawa Y
    Blood; 2001 Jan; 97(1):175-82. PubMed ID: 11133758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid residues in the alpha IIb subunit that are critical for ligand binding to integrin alpha IIbbeta 3 are clustered in the beta-propeller model.
    Kamata T; Tieu KK; Irie A; Springer TA; Takada Y
    J Biol Chem; 2001 Nov; 276(47):44275-83. PubMed ID: 11557768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
    Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
    Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insights from a refined three-dimensional model of integrin alphaIIbbeta3.
    Filizola M; Hassan SA; Artoni A; Coller BS; Weinstein H
    J Biol Chem; 2004 Jun; 279(23):24624-30. PubMed ID: 15056669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site.
    Bajt ML; Ginsberg MH; Frelinger AL; Berndt MC; Loftus JC
    J Biol Chem; 1992 Feb; 267(6):3789-94. PubMed ID: 1371279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of integrin alpha IIbbeta 3 clustering in living cells.
    Buensuceso C; de Virgilio M; Shattil SJ
    J Biol Chem; 2003 Apr; 278(17):15217-24. PubMed ID: 12595537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects.
    Kiyoi T; Tomiyama Y; Honda S; Tadokoro S; Arai M; Kashiwagi H; Kosugi S; Kato H; Kurata Y; Matsuzawa Y
    Blood; 2003 May; 101(9):3485-91. PubMed ID: 12506038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering.
    Luo BH; Carman CV; Takagi J; Springer TA
    Proc Natl Acad Sci U S A; 2005 Mar; 102(10):3679-84. PubMed ID: 15738420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.